Medtronic plc (MDT)
USD 83.41
(0.62%)
USD 83.41
(0.62%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 39.56 Billion USD | 0.71% |
| 2023 | 39.28 Billion USD | 2.68% |
| 2022 | 38.25 Billion USD | -7.77% |
| 2021 | 41.48 Billion USD | 4.18% |
| 2020 | 39.81 Billion USD | 0.85% |
| 2019 | 39.48 Billion USD | -2.68% |
| 2018 | 40.57 Billion USD | -17.87% |
| 2017 | 49.4 Billion USD | 3.52% |
| 2016 | 47.71 Billion USD | -10.73% |
| 2015 | 53.45 Billion USD | 188.95% |
| 2014 | 18.5 Billion USD | 14.74% |
| 2013 | 16.12 Billion USD | 0.96% |
| 2012 | 15.97 Billion USD | 10.47% |
| 2011 | 14.45 Billion USD | 7.39% |
| 2010 | 13.46 Billion USD | 24.52% |
| 2009 | 10.81 Billion USD | 1.39% |
| 2008 | 10.66 Billion USD | 24.92% |
| 2007 | 8.53 Billion USD | -16.99% |
| 2006 | 10.28 Billion USD | 66.71% |
| 2005 | 6.16 Billion USD | 22.53% |
| 2004 | 5.03 Billion USD | 14.03% |
| 2003 | 4.41 Billion USD | -1.32% |
| 2002 | 4.47 Billion USD | 192.49% |
| 2001 | 1.52 Billion USD | 29.84% |
| 2000 | 1.17 Billion USD | -3.11% |
| 1999 | 1.21 Billion USD | 66.42% |
| 1998 | 730.5 Million USD | 10.18% |
| 1997 | 663 Million USD | -7.14% |
| 1996 | 714 Million USD | 16.72% |
| 1995 | 611.7 Million USD | 7.35% |
| 1994 | 569.8 Million USD | 28.04% |
| 1993 | 445 Million USD | 21.25% |
| 1992 | 367 Million USD | 7.66% |
| 1991 | 340.9 Million USD | 8.05% |
| 1990 | 315.5 Million USD | 10.31% |
| 1989 | 286 Million USD | 16.78% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 38.44 Billion USD | -2.46% |
| 2024 Q1 | 39.41 Billion USD | 0.32% |
| 2024 FY | 39.56 Billion USD | 0.71% |
| 2024 Q3 | 38.84 Billion USD | 1.04% |
| 2024 Q4 | 39.56 Billion USD | 1.85% |
| 2023 FY | 39.28 Billion USD | 2.68% |
| 2023 Q4 | 39.28 Billion USD | -7.6% |
| 2023 Q2 | 41.18 Billion USD | 11.09% |
| 2023 Q1 | 37.07 Billion USD | -3.1% |
| 2023 Q3 | 42.51 Billion USD | 3.23% |
| 2022 FY | 38.25 Billion USD | -7.77% |
| 2022 Q2 | 39.59 Billion USD | -1.35% |
| 2022 Q3 | 39.09 Billion USD | -1.28% |
| 2022 Q4 | 38.26 Billion USD | -2.13% |
| 2022 Q1 | 40.13 Billion USD | -3.24% |
| 2021 Q3 | 46.34 Billion USD | 1.69% |
| 2021 Q1 | 43.46 Billion USD | 9.16% |
| 2021 Q4 | 41.48 Billion USD | -10.49% |
| 2021 FY | 41.48 Billion USD | 4.18% |
| 2021 Q2 | 45.57 Billion USD | 4.85% |
| 2020 Q1 | 40.77 Billion USD | 3.26% |
| 2020 Q3 | 40.86 Billion USD | 1.33% |
| 2020 Q2 | 40.33 Billion USD | -1.07% |
| 2020 FY | 39.81 Billion USD | 0.85% |
| 2020 Q4 | 39.81 Billion USD | -2.57% |
| 2019 Q3 | 38.78 Billion USD | 0.92% |
| 2019 Q2 | 38.43 Billion USD | -2.43% |
| 2019 Q1 | 39.39 Billion USD | -2.91% |
| 2019 Q4 | 39.48 Billion USD | 1.79% |
| 2019 FY | 39.48 Billion USD | -2.68% |
| 2018 Q3 | 45.46 Billion USD | 6.02% |
| 2018 FY | 40.57 Billion USD | -17.87% |
| 2018 Q2 | 42.88 Billion USD | -13.16% |
| 2018 Q4 | 40.57 Billion USD | -10.75% |
| 2018 Q1 | 49.38 Billion USD | -0.04% |
| 2017 Q4 | 49.4 Billion USD | 2.73% |
| 2017 FY | 49.4 Billion USD | 3.52% |
| 2017 Q3 | 48.08 Billion USD | -0.06% |
| 2017 Q2 | 48.11 Billion USD | 0.85% |
| 2017 Q1 | 47.7 Billion USD | -0.02% |
| 2016 Q2 | 52.67 Billion USD | 1.66% |
| 2016 Q3 | 51.89 Billion USD | -1.49% |
| 2016 Q4 | 47.71 Billion USD | -8.04% |
| 2016 FY | 47.71 Billion USD | -10.73% |
| 2016 Q1 | 51.81 Billion USD | -3.06% |
| 2015 Q3 | 35.06 Billion USD | 81.26% |
| 2015 Q2 | 19.34 Billion USD | 5.66% |
| 2015 Q1 | 18.3 Billion USD | -1.05% |
| 2015 FY | 53.45 Billion USD | 188.95% |
| 2015 Q4 | 53.45 Billion USD | 52.47% |
| 2014 Q1 | 16.36 Billion USD | 1.5% |
| 2014 Q4 | 18.5 Billion USD | 3.48% |
| 2014 Q3 | 17.87 Billion USD | 0.86% |
| 2014 FY | 18.5 Billion USD | 14.74% |
| 2014 Q2 | 17.72 Billion USD | 8.3% |
| 2013 Q3 | 17.11 Billion USD | 1.95% |
| 2013 Q4 | 16.12 Billion USD | -5.79% |
| 2013 Q1 | 15.99 Billion USD | 0.17% |
| 2013 Q2 | 16.78 Billion USD | 4.93% |
| 2013 FY | 16.12 Billion USD | 0.96% |
| 2012 Q1 | 14.75 Billion USD | 2.04% |
| 2012 Q3 | 14.74 Billion USD | -1.81% |
| 2012 Q4 | 15.97 Billion USD | 8.33% |
| 2012 FY | 15.97 Billion USD | 10.47% |
| 2012 Q2 | 15.01 Billion USD | 1.78% |
| 2011 Q2 | 14.48 Billion USD | 3.04% |
| 2011 Q1 | 14.05 Billion USD | 4.44% |
| 2011 FY | 14.45 Billion USD | 7.39% |
| 2011 Q4 | 14.45 Billion USD | -5.14% |
| 2011 Q3 | 15.23 Billion USD | 5.2% |
| 2010 Q2 | 10.67 Billion USD | 2.36% |
| 2010 FY | 13.46 Billion USD | 24.52% |
| 2010 Q1 | 10.43 Billion USD | -3.52% |
| 2010 Q4 | 13.46 Billion USD | 24.09% |
| 2010 Q3 | 10.84 Billion USD | 1.61% |
| 2009 Q2 | 9.4 Billion USD | -10.34% |
| 2009 Q4 | 10.81 Billion USD | 11.44% |
| 2009 Q3 | 9.7 Billion USD | 3.09% |
| 2009 Q1 | 10.49 Billion USD | -1.58% |
| 2009 FY | 10.81 Billion USD | 1.39% |
| 2008 Q3 | 10.44 Billion USD | 14.65% |
| 2008 FY | 10.66 Billion USD | 24.92% |
| 2008 Q1 | 8.51 Billion USD | -0.21% |
| 2008 Q4 | 10.66 Billion USD | 2.07% |
| 2008 Q2 | 9.11 Billion USD | 6.97% |
| 2007 FY | 8.53 Billion USD | -16.99% |
| 2007 Q3 | 8.58 Billion USD | -0.36% |
| 2007 Q4 | 8.53 Billion USD | -0.62% |
| 2007 Q2 | 8.61 Billion USD | -16.2% |
| 2007 Q1 | 10.28 Billion USD | 0.03% |
| 2006 Q3 | 6.6 Billion USD | -0.49% |
| 2006 Q1 | 6.33 Billion USD | 2.73% |
| 2006 Q2 | 6.63 Billion USD | 4.69% |
| 2006 FY | 10.28 Billion USD | 66.71% |
| 2006 Q4 | 10.28 Billion USD | 55.76% |
| 2005 Q2 | 5.25 Billion USD | 2.86% |
| 2005 Q1 | 5.1 Billion USD | 1.49% |
| 2005 FY | 6.16 Billion USD | 22.53% |
| 2005 Q3 | 5.46 Billion USD | 3.96% |
| 2005 Q4 | 6.16 Billion USD | 12.9% |
| 2004 FY | 5.03 Billion USD | 14.03% |
| 2004 Q1 | 4.45 Billion USD | 0.81% |
| 2004 Q2 | 4.59 Billion USD | 3.35% |
| 2004 Q3 | 4.75 Billion USD | 3.28% |
| 2004 Q4 | 5.03 Billion USD | 5.97% |
| 2003 FY | 4.41 Billion USD | -1.32% |
| 2003 Q2 | 4.26 Billion USD | -4.29% |
| 2003 Q3 | 4.34 Billion USD | 1.68% |
| 2003 Q4 | 4.41 Billion USD | 1.7% |
| 2003 Q1 | 4.46 Billion USD | -0.29% |
| 2002 Q2 | 3.88 Billion USD | 158.92% |
| 2002 FY | 4.47 Billion USD | 192.49% |
| 2002 Q4 | 4.47 Billion USD | 12.33% |
| 2002 Q3 | 3.98 Billion USD | 2.45% |
| 2002 Q1 | 1.5 Billion USD | -1.84% |
| 2001 Q3 | 1.15 Billion USD | -4.46% |
| 2001 Q4 | 1.52 Billion USD | 32.59% |
| 2001 Q1 | 1.14 Billion USD | -2.62% |
| 2001 Q2 | 1.2 Billion USD | 5.27% |
| 2001 FY | 1.52 Billion USD | 29.84% |
| 2000 Q1 | 1.19 Billion USD | -1.97% |
| 2000 FY | 1.17 Billion USD | -3.11% |
| 2000 Q2 | 1.31 Billion USD | 10.06% |
| 2000 Q3 | 1.3 Billion USD | -0.69% |
| 2000 Q4 | 1.17 Billion USD | -9.57% |
| 1999 FY | 1.21 Billion USD | 66.42% |
| 1999 Q3 | 1.33 Billion USD | 44.43% |
| 1999 Q1 | 719.8 Million USD | -1.46% |
| 1999 Q2 | 924.5 Million USD | 28.44% |
| 1999 Q4 | 1.21 Billion USD | -8.96% |
| 1998 Q2 | 667.5 Million USD | -1.1% |
| 1998 Q1 | 674.9 Million USD | 1.79% |
| 1998 Q3 | 767.5 Million USD | 14.98% |
| 1998 FY | 730.5 Million USD | 10.18% |
| 1998 Q4 | 730.5 Million USD | -4.82% |
| 1997 FY | 663 Million USD | -7.14% |
| 1997 Q3 | 662 Million USD | 1.41% |
| 1997 Q4 | 663 Million USD | 0.15% |
| 1997 Q2 | 652.8 Million USD | 0.55% |
| 1997 Q1 | 649.2 Million USD | -9.08% |
| 1996 FY | 714 Million USD | 16.72% |
| 1996 Q2 | 566.2 Million USD | -5.88% |
| 1996 Q3 | 574.7 Million USD | 1.5% |
| 1996 Q4 | 714 Million USD | 24.24% |
| 1996 Q1 | 601.6 Million USD | -1.65% |
| 1995 Q1 | 548.5 Million USD | -3.74% |
| 1995 FY | 611.7 Million USD | 7.35% |
| 1995 Q2 | 519.8 Million USD | -5.23% |
| 1995 Q3 | 514.3 Million USD | -1.06% |
| 1995 Q4 | 611.7 Million USD | 18.94% |
| 1994 Q2 | 361.3 Million USD | -7.19% |
| 1994 FY | 569.8 Million USD | 28.04% |
| 1994 Q4 | 569.8 Million USD | 44.4% |
| 1994 Q1 | 389.3 Million USD | -12.52% |
| 1994 Q3 | 394.6 Million USD | 9.22% |
| 1993 Q4 | 445 Million USD | 10.5% |
| 1993 Q3 | 402.7 Million USD | 2.97% |
| 1993 Q2 | 391.1 Million USD | 19.38% |
| 1993 Q1 | 327.6 Million USD | -10.74% |
| 1993 FY | 445 Million USD | 21.25% |
| 1992 Q1 | 304.9 Million USD | -10.56% |
| 1992 Q4 | 367 Million USD | 8.29% |
| 1992 Q3 | 338.9 Million USD | 5.41% |
| 1992 FY | 367 Million USD | 7.66% |
| 1992 Q2 | 321.5 Million USD | 5.44% |
| 1991 Q2 | 336.1 Million USD | 6.6% |
| 1991 Q1 | 315.3 Million USD | -0.06% |
| 1991 FY | 340.9 Million USD | 8.05% |
| 1991 Q4 | 340.9 Million USD | 6.97% |
| 1991 Q3 | 318.7 Million USD | -5.18% |
| 1990 FY | 315.5 Million USD | 10.31% |
| 1990 Q4 | 315.5 Million USD | 9.82% |
| 1990 Q3 | 287.3 Million USD | 3.46% |
| 1990 Q2 | 277.7 Million USD | 0.0% |
| 1989 FY | 286 Million USD | 16.78% |
| 1989 Q4 | 286 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott Laboratories | 34.38 Billion USD | -15.046% |
| Allurion Technologies Inc. | 142.19 Million USD | -27720.871% |
| Artivion, Inc. | 510.61 Million USD | -7647.686% |
| Avanos Medical, Inc. | 456.1 Million USD | -8573.756% |
| Butterfly Network, Inc. | 84.22 Million USD | -46872.845% |
| Butterfly Network, Inc. | 84.22 Million USD | -46872.845% |
| Bio-Rad Laboratories, Inc. | 3.55 Billion USD | -1011.908% |
| Boston Scientific Corporation | 15.6 Billion USD | -153.499% |
| CONMED Corporation | 1.46 Billion USD | -2598.938% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | -1396.369% |
| Paragon 28, Inc. | 162.95 Million USD | -24176.808% |
| Glaukos Corporation | 478.64 Million USD | -8165.155% |
| Globus Medical, Inc. | 1.08 Billion USD | -3535.707% |
| Inspire Medical Systems, Inc. | 104.29 Million USD | -37831.101% |
| Integer Holdings Corporation | 1.41 Billion USD | -2699.346% |
| Myomo, Inc. | 5.59 Million USD | -707329.503% |
| Nevro Corp. | 330.31 Million USD | -11876.895% |
| Owlet, Inc. | 73.79 Million USD | -53506.417% |
| Penumbra, Inc. | 377.36 Million USD | -10383.595% |
| Vicarious Surgical Inc. | 21.89 Million USD | -180585.088% |
| Smith & Nephew plc | 4.77 Billion USD | -729.371% |
| Sonendo, Inc. | 49.74 Million USD | -79433.986% |
| STERIS plc | 4.74 Billion USD | -733.152% |
| Stryker Corporation | 21.31 Billion USD | -85.567% |
| Vapotherm, Inc. | 132.95 Million USD | -29656.076% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | -339.142% |